Market Overview

Cyberonics Announces Results from E-36 Study Of AspireSR Generator at AES


Cyberonics (NASDAQ: CYBX) announced today that results from the E-36 clinical study of the AspireSR generator were presented at the annual  AES Meeting, taking place December 6-10 at the Walter E. Washington Convention Center in Washington, D.C.  

The study met its primary endpoint in that the AspireSR generator, with IntelliSense cardiac-based seizure detection, detected more than

See full press release

Posted-In: News Guidance Management Global


Related Articles (CYBX)

View Comments and Join the Discussion!

Benzinga's Weekend M&A Chatter

Disney's 'Frozen' Grosses $31.6M this Weekend; Lionsgate's 'The Hunger Games: Catching Fire' Global Total Now $673.4M